These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9622548)

  • 21. The crystal structure of alpha-thrombin-hirunorm IV complex reveals a novel specificity site recognition mode.
    Lombardi A; De Simone G; Nastri F; Galdiero S; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V
    Protein Sci; 1999 Jan; 8(1):91-5. PubMed ID: 10210187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor.
    Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1227-33. PubMed ID: 15504346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of ligand conformations in continuum solvent consistent with protein active site topology: application to thrombin.
    Greenidge PA; Mérette SA; Beck R; Dodson G; Goodwin CA; Scully MF; Spencer J; Weiser J; Deadman JJ
    J Med Chem; 2003 Apr; 46(8):1293-305. PubMed ID: 12672230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and SAR of thrombin inhibitors incorporating a novel 4-amino-morpholinone sscaffold: analysis of X-ray crystal structure of enzyme inhibitor complex.
    Nilsson JW; Kvarnström I; Musil D; Nilsson I; Samulesson B
    J Med Chem; 2003 Sep; 46(19):3985-4001. PubMed ID: 12954052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
    Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M
    J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
    Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
    J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of non-peptide PAR1 thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activity.
    Androutsou ME; Saifeddine M; Hollenberg MD; Matsoukas J; Agelis G
    Amino Acids; 2010 Apr; 38(4):985-90. PubMed ID: 19484400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models.
    Bertrand JA; Oleksyszyn J; Kam CM; Boduszek B; Presnell S; Plaskon RR; Suddath FL; Powers JC; Williams LD
    Biochemistry; 1996 Mar; 35(10):3147-55. PubMed ID: 8605148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19.
    Girnys EA; Sobczyk-Kojiro K; Mosberg HI
    Chem Biol Drug Des; 2010 Jan; 75(1):35-9. PubMed ID: 19954432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catalytic mechanism of guanidinoacetate methyltransferase: crystal structures of guanidinoacetate methyltransferase ternary complexes.
    Komoto J; Yamada T; Takata Y; Konishi K; Ogawa H; Gomi T; Fujioka M; Takusagawa F
    Biochemistry; 2004 Nov; 43(45):14385-94. PubMed ID: 15533043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position.
    Tucker TJ; Brady SF; Lumma WC; Lewis SD; Gardell SJ; Naylor-Olsen AM; Yan Y; Sisko JT; Stauffer KJ; Lucas BJ; Lynch JJ; Cook JJ; Stranieri MT; Holahan MA; Lyle EA; Baskin EP; Chen IW; Dancheck KB; Krueger JA; Cooper CM; Vacca JP
    J Med Chem; 1998 Aug; 41(17):3210-9. PubMed ID: 9703466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2.
    Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP
    Biochemistry; 1999 Jul; 38(29):9221-33. PubMed ID: 10413496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SSR182289A, a selective and potent orally active thrombin inhibitor.
    Altenburger JM; Lassalle GY; Matrougui M; Galtier D; Jetha JC; Bocskei Z; Berry CN; Lunven C; Lorrain J; Herault JP; Schaeffer P; O'Connor SE; Herbert JM
    Bioorg Med Chem; 2004 Apr; 12(7):1713-30. PubMed ID: 15028263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker.
    Slon-Usakiewicz JJ; Purisima E; Tsuda Y; Sulea T; Pedyczak A; Féthière J; Cygler M; Konishi Y
    Biochemistry; 1997 Nov; 36(44):13494-502. PubMed ID: 9354617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
    Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
    J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
    Johansson E; Parkinson GN; Denny WA; Neidle S
    J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel natural product 5,5-trans-lactone inhibitors of human alpha-thrombin: mechanism of action and structural studies.
    Weir MP; Bethell SS; Cleasby A; Campbell CJ; Dennis RJ; Dix CJ; Finch H; Jhoti H; Mooney CJ; Patel S; Tang CM; Ward M; Wonacott AJ; Wharton CW
    Biochemistry; 1998 May; 37(19):6645-57. PubMed ID: 9578548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
    Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template.
    Jhoti H; Cleasby A; Reid S; Thomas PJ; Weir M; Wonacott A
    Biochemistry; 1999 Jun; 38(25):7969-77. PubMed ID: 10387040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.